|
2024-02-02 |
2024-02-01 |
PS
Planned sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
15,000
-4.0%
15.29
USD 229,386
|
15,000
-4.0%
|
15.29
|
USD 229,386
|
|
|
2024-01-04 |
2024-01-02 |
PS
Planned sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
15,000
-5.4%
15.67
USD 235,088
|
15,000
-5.4%
|
15.67
|
USD 235,088
|
|
|
2023-12-22 |
2023-12-21 |
S
Sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
40,000
-13.3%
15.43
USD 617,060
|
40,000
-13.3%
|
15.43
|
USD 617,060
|
|
|
2023-12-22 |
2023-12-21 |
PS
Planned sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
50,000
-14.3%
15.44
USD 772,220
|
50,000
-14.3%
|
15.44
|
USD 772,220
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Kanesa-thasan Niranjan
Chief Medical Officer
Officer
|
11,884
-5.0%
15.46
USD 183,692
|
11,884
-5.0%
|
15.46
|
USD 183,692
|
|
|
2023-12-22 |
2023-12-20 |
S
Sale
|
Russo Thomas Joseph
Chief Financial Officer
Officer
|
4,430
-10.4%
15.47
USD 68,510
|
4,430
-10.4%
|
15.47
|
USD 68,510
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Russo Thomas Joseph
Chief Financial Officer
Officer
|
10,753
-20.2%
15.46
USD 166,210
|
10,753
-20.2%
|
15.46
|
USD 166,210
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
62,205
-25.2%
15.46
USD 961,509
|
62,205
-25.2%
|
15.46
|
USD 961,509
|
|
|
2023-12-22 |
2023-12-20 |
PS
Planned sale
|
Cearley Cassia
Chief Business Officer
Officer
|
7,934
-5.7%
15.46
USD 122,637
|
7,934
-5.7%
|
15.46
|
USD 122,637
|
|
|
2023-12-15 |
2023-12-13 |
PS
Planned sale
|
Cearley Cassia
Chief Business Officer
Officer
|
8,759
-6.3%
16.01
USD 140,190
|
8,759
-6.3%
|
16.01
|
USD 140,190
|
|
|
2023-08-01 |
2023-07-31 |
PS
Planned sale
|
Russo Thomas Joseph
Chief Financial Officer
Officer
|
3,066
-6.3%
8.86
USD 27,169
|
3,066
-6.3%
|
8.86
|
USD 27,169
|
|
|
2023-08-01 |
2023-07-31 |
PS
Planned sale
|
Simpson Adam K.
Chief Executive Officer
Executive Director
|
11,788
-4.6%
8.86
USD 104,459
|
11,788
-4.6%
|
8.86
|
USD 104,459
|
|
|
2023-08-01 |
2023-07-31 |
PS
Planned sale
|
Cearley Cassia
Chief Business Officer
Officer
|
1,888
-1.3%
8.86
USD 16,731
|
1,888
-1.3%
|
8.86
|
USD 16,731
|
|
|
2023-08-01 |
2023-07-31 |
PS
Planned sale
|
Kanesa-thasan Niranjan
Chief Medical Officer
Officer
|
3,323
-1.4%
8.86
USD 29,447
|
3,323
-1.4%
|
8.86
|
USD 29,447
|
|
|
2023-07-03 |
2023-07-03 |
PS
Planned sale
|
Holtzman Douglas
Chief Scientific Officer
Officer
|
2,095
-0.7%
9.59
USD 20,083
|
2,095
-0.7%
|
9.59
|
USD 20,083
|
|
|
2023-07-03 |
2023-07-03 |
PS
Planned sale
|
Holtzman Douglas
Chief Scientific Officer
Officer
|
14,261
-4.7%
8.74
USD 124,660
|
14,261
-4.7%
|
8.74
|
USD 124,660
|
|
|
2023-05-25 |
2023-05-23 |
PS
Planned sale
|
Cearley Cassia
Chief Business Officer
Officer
|
10,000
-6.6%
10.00
USD 100,000
|
10,000
-6.6%
|
10.00
|
USD 100,000
|
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Holtzman Douglas
Chief Scientific Officer
Officer
|
300
-0.1%
6.56
USD 1,968
|
300
-0.1%
|
6.56
|
USD 1,968
|
|
|
2023-04-05 |
2023-04-03 |
PS
Planned sale
|
Holtzman Douglas
Chief Scientific Officer
Officer
|
20,143
-6.5%
6.08
USD 122,439
|
20,143
-6.5%
|
6.08
|
USD 122,439
|
|
|
2023-03-08 |
2023-03-06 |
PS
Planned sale
|
Cearley Cassia
Chief Business Officer
Officer
|
5,000
-3.2%
7.75
USD 38,737
|
5,000
-3.2%
|
7.75
|
USD 38,737
|
|
